Cellerant Therapeutics' Series B - II Round

Cellerant Therapeutics raised a round of funding on September 16, 2005.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies…

Articles about Cellerant Therapeutics' Series B - II Round: